Gregg O Lehman - 16 Jun 2023 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Jun 2023, 20:05:08 UTC
Prior SEC filing
19 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin Whitman, Attorney-in-Fact for Gregg O. Lehman

Key filing fact

Gregg O Lehman filed Form 4 for InfuSystem Holdings, Inc (INFU) on 20 Jun 2023.

Key facts

  • This page summarizes Gregg O Lehman's Form 4 filing for InfuSystem Holdings, Inc (INFU).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 20 Jun 2023, 20:05.

Change

  • Previous filing in this sequence was filed on 19 May 2023.
  • Current net transaction value: -$227,698.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INFU transaction

Common Stock

Options Exercise

Transaction value
$214,500
Shares
+25,000
Change %
+7225%
Price
$8.58
Shares after
25,346
Date
16 Jun 2023
Ownership
Direct
INFU transaction

Common Stock

Sale

Transaction value
$227,698
Shares
-25,000
Change %
-99%
Price
$9.11
Shares after
346
Date
16 Jun 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INFU transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$214,500
Shares
-25,000
Change %
-100%
Price
$8.58
Shares after
0
Date
16 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,000
Exercise price
$8.58
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares reported herein were sold in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F2

The option, representing the right to purchase 25,000 shares of InfuSystem Holdings, Inc. common stock, vested on the date of the 2023 annual shareholder meeting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .